163 related articles for article (PubMed ID: 1968955)
1. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
Ben-Shachar D; Youdim MB
J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955
[TBL] [Abstract][Full Text] [Related]
2. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
Ben-Shachar D; Pinhassi B; Youdim MB
Eur J Pharmacol; 1991 Sep; 202(2):177-83. PubMed ID: 1687031
[TBL] [Abstract][Full Text] [Related]
3. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
[TBL] [Abstract][Full Text] [Related]
4. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
Pierce RC; Rowlett JK; Bardo MT; Rebec GV
Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
[TBL] [Abstract][Full Text] [Related]
5. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
6. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
Bhargava HN
Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
[TBL] [Abstract][Full Text] [Related]
8. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
9. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
Prasad C; Spahn SA; Ikegami H
Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
[TBL] [Abstract][Full Text] [Related]
10. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission.
Calabresi P; De Murtas M; Mercuri NB; Bernardi G
Ann Neurol; 1992 Apr; 31(4):366-73. PubMed ID: 1350190
[TBL] [Abstract][Full Text] [Related]
11. Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment.
Agnati LF; Fuxe K; Benfenati F; Battistini N; Zini I; Toffano G
Neurosci Lett; 1983 Oct; 40(3):293-7. PubMed ID: 6646502
[TBL] [Abstract][Full Text] [Related]
12. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
[TBL] [Abstract][Full Text] [Related]
13. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
14. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
Shapiro LA; Offord SJ; Ordway GA
Brain Res; 1995 Apr; 677(2):250-6. PubMed ID: 7552250
[TBL] [Abstract][Full Text] [Related]
15. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
Fields JZ; Gordon JH
Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
Schröder U; Schröder H; Augustin W; Sabel BA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
[TBL] [Abstract][Full Text] [Related]
17. Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens.
Youdim MB; Sills MA; Heydorn WE; Creed GJ; Jacobowitz DM
J Neurochem; 1986 Sep; 47(3):794-9. PubMed ID: 2942640
[TBL] [Abstract][Full Text] [Related]
18. Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptake.
Ben-Shachar D; Livne E; Spanier I; Leenders KL; Youdim MB
J Neurochem; 1994 Mar; 62(3):1112-8. PubMed ID: 7906714
[TBL] [Abstract][Full Text] [Related]
19. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
Tecott LH; Kwong LL; Uhr S; Peroutka SJ
Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]